Our vision as a company is only possible if patients can have equal access to healthcare. We know the system doesn’t work for everyone, and the COVID-19 pandemic further highlighted disparities in access to treatment. Together, we can work to provide all patients with fair and just opportunities to achieve optimal health. We know we have a role to play in addressing health equity, and we are taking steps to contribute in areas where we can make a difference. Our commitments include a determined focus on addressing health disparities and increasing clinical trial diversity.
Even as we deepen our efforts to address disparities in healthcare, we understand the responsibility we have to address racial or societal inequity wherever we see it. Following the death of George Floyd, Bristol Myers Squibb built upon our extensive experience in diversity and inclusion to amplify our efforts and make strategic commitments to accelerate diversity and inclusion. More specifically, our commitments include achieving gender parity at the executive level globally and doubling executive representation of Black/African American and Latino/Hispanic employees in the U.S. by the end of 2022.